Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
about
Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients.Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory.Delayed efficient anticoagulation with heparin in patients with a weight of 110 kg and more treated for acute coronary syndrome.Influence of Body Mass Index on the Activated Clotting Time Under Weight-Based Heparin Dose.Relation Between TRCA Complication Rates and Peak ACT Levels Stratified According to the BMI Tertiles.
P2860
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@en
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@nl
type
label
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@en
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@nl
prefLabel
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@en
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@nl
P2093
P2860
P356
P1476
Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
@en
P2093
Andrea M Wessell
Sarah J Schwiesow
Terrence E Steyer
P2860
P304
P356
10.1345/APH.1E300
P407
P577
2005-03-01T00:00:00Z